Delanzo DR 30mg Capsules (30s)

Description

Delanzo DR is a delayed-release proton pump inhibitor capsule containing dexlansoprazole. It reduces gastric acid production and is used for acid-related gastroesophageal conditions such as heartburn and gastroesophageal reflux disease.

• Manufacturer Name: Sami
• Drug Class: Proton pump inhibitor
• Dosage Form: Dual Delayed-Release Capsule
• Storage: Store at room temperature in a dry place, protected from direct light, heat, and moisture. Keep out of reach of children.
• Pack Size: Pack of 30 Capsules

Delanzo DR 30mg Capsules (30s) Available Online in Pakistan

Dwatson offers Delanzo DR 30mg Capsules (30s) at Rs.765, with fast, discreet delivery across Pakistan.

Ingredients

• Dexlansoprazole 30 mg

Benefits

• Relief of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease.
• Maintenance of healing of erosive esophagitis and relief of associated heartburn.
• Reduction of excessive gastric acid production in appropriate acid-related disorders.

Usage & Safety

For Adult

• For symptomatic non-erosive gastroesophageal reflux disease: 30 mg once daily for up to 4 weeks.
• For maintenance of healed erosive esophagitis and relief of heartburn: 30 mg once daily, according to medical advice.
• Swallow the capsule whole; do not crush or chew the contents. It may be taken with or without food.
• Use the lowest effective dose for the shortest appropriate duration.

For Children

• Use in patients 12 years and older only under medical supervision.
• Safety and effectiveness in children younger than 12 years have not been established for this product.
• Pediatric dosing should be determined by a healthcare professional; do not use solely on the basis of body weight without medical advice.

Side Effects

• Common effects may include diarrhea, abdominal pain, nausea, vomiting, flatulence, headache, and upper respiratory tract symptoms.
• Contact a healthcare professional for persistent or severe diarrhea, especially if accompanied by fever or abdominal pain.
• Serious reactions may include severe allergic reaction, kidney inflammation, low magnesium, vitamin B12 deficiency, severe skin reactions, or fractures associated with prolonged use.

Contraindications

• Do not use in patients with known hypersensitivity to dexlansoprazole, other proton pump inhibitors, or any formulation ingredient.
• Do not use with rilpivirine-containing medicines.
• Avoid or use only under specialist supervision in severe hepatic impairment.
• Seek medical assessment for alarm symptoms such as difficulty swallowing, vomiting blood, black stools, unexplained weight loss, or persistent vomiting.
• Long-term or high-dose use should be medically reviewed because of possible risks including low magnesium, vitamin B12 deficiency, bone fractures, and gastrointestinal infections.

Precautions & Warnings

• Do not combine with rilpivirine-containing products.
• Use caution with warfarin, digoxin, methotrexate at high doses, tacrolimus, mycophenolate mofetil, and medicines whose absorption depends on stomach acidity.
• Acid-dependent medicines that may be affected include certain HIV medicines, antifungals such as ketoconazole or itraconazole, and some anticancer medicines such as erlotinib, dasatinib, and nilotinib.
• Tell the healthcare professional about iron salts, diuretics, St. John’s wort, rifampicin, or voriconazole.
• Alcohol and foods are not known to produce a specific major interaction, but foods or drinks that trigger reflux may worsen symptoms.

Pregnancy

• Use during pregnancy only when clearly needed and after consultation with a healthcare professional.
• Available proton pump inhibitor data do not suggest a major overall fetal risk, but specific pregnancy data for dexlansoprazole are limited.
• Discuss breastfeeding before use. Available information is limited; a healthcare professional should weigh the benefits of treatment against potential infant exposure.